Laurence Egan
National University of Ireland, Galway
H-index: 44
Europe-Ireland
Top articles of Laurence Egan
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The performance indicator of colonic intubation (PICI) in an Irish Inflammatory Bowel Disease (IBD) cohort | Scandinavian Journal of Gastroenterology | Martin Lund Rune Erichsen Sisse Helle Njor Søren Laurberg Roland Valori | 2019/9/2 |
DOP15 Results of a pragmatic multicentred randomised controlled trial investigating the use of personalised golimumab dosing in Ulcerative Colitis: the GOAL-ARC study (GLM dose … | Journal of Crohn's and Colitis | G Doherty C Coe L Egan D Kevans A O'Toole | 2024/1/1 |
P523 The performance indicator of colonic intubation (PICI) in an Irish Inflammatory Bowel Disease (IBD) cohort | Journal of Crohn's and Colitis | F Jones A Lavelle F McCarthy S Patchett A Morcos | 2024/1/1 |
967 Inflammatory tumour microenvironment in CRC alters macrophage function through mesenchymal stromal cell PD-1/PD-L1 signalling | Niamh Leonard Shania Corry Oliver Treacy Eileen Reidy Keara Redmond | 2023/11/1 | |
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment | Cell Reports | Hannah Egan Oliver Treacy Kevin Lynch Niamh A Leonard Grace O’Malley | 2023/5/30 |
Tu1790 COMBINATION BIOLOGIC OR SMALL MOLECULE THERAPY IN INFLAMMATORY BOWEL DISEASE | Gastroenterology | Catherine Mcshane Rachel Varley Anne Fennessy John R Campion Karl Hazel | 2023/5/1 |
I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease | Clinical Gastroenterology and Hepatology | Laurent Peyrin-Biroulet Jean-François Rahier Julien Kirchgesner Vered Abitbol Sebastian Shaji | 2023/3/1 |
P483 Golimumab response in Ulcerative Colitis as early as week 2: What can we take from this? | Journal of Crohn's and Colitis | L Kumar N O’Morain J Sheridan C Coe C Egan | 2023/2/1 |
1444 Targeting sialic acid on stromal cells reverses T cell suppression in the colorectal tumour microenvironment a new tumour stromal cell immune checkpoint | Aideen Ryan Oliver Treacy Kevin Lynch Kim De Veirman Karin Vanderkerken | 2022/11/1 | |
Review of recent evidence on the management of heartburn in pregnant and breastfeeding women | Raja Affendi Raja Ali Jamiyah Hassan Laurence J Egan | 2022/5/4 | |
Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease | Biomaterials | Niranjan G Kotla Rajbir Singh Becca V Baby Swetha Rasala Jawad Rasool | 2022/2/1 |
Endoscopy Capsule Retention in a Young Female with Small Bowel Strictures Secondary to Non-Steroidal Anti-Inflammatory Drugs | Case Reports in Gastroenterology | Muhammad Umair Tayyub Laurence Egan Carol Goulding | 2022/1/6 |
P452 Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis | Journal of Crohn's and Colitis | M McNally E Keating E Gray E McCormick A Carroll | 2022/1/1 |
941 Stromal cell sialylation suppresses T cells in inflammatory tumour microenvironments: a new tumour stromal cell immune checkpoint? | Oliver Treacy Hannah Egan Kevin Lynch Niamh Leonard Kim De Veirman | 2021/11/1 | |
Stromal cell sialylation suppresses T cells in inflammatory tumour microenvironments: A new tumour stromal cell immune checkpoint? | bioRxiv | Hannah Egan Oliver Treacy Kevin Lynch Niamh A Leonard Grace O’Malley | 2021/6/18 |
Subtotal colectomy in ulcerative colitis—Long term considerations for the rectal stump | World Journal of Gastrointestinal Surgery | Orla Hennessy Laurence Egan Myles Joyce | 2021/2/2 |
AB066. Elucidating the circulating and tumour-specific immune populations in a cohort of colon cancer patients | Mesentery and Peritoneum | Amir Nader Wadie Samy Oliver Treacy Niamh Leonard Kevin Lynch Sean Hynes | 2020/3/2 |
Comparison of medium to long-term outcomes of acute severe ulcerative colitis patients receiving accelerated and standard infliximab induction | Frontline Gastroenterology | David J Gibson Jayne Doherty Mairead McNally John Campion Denise Keegan | 2020/11/1 |
FLIP (L) determines colon cancer cell fate following p53 activation | Cancer Research | Andrea Lees Alexander J McIntyre J McIntyre Nyree T Crawford Fiammetta Falcone Chris McCann | 2020/8/15 |
The pseudo-caspase FLIP (L) regulates cell fate following p53 activation | Proceedings of the National Academy of Sciences | Andrea Lees Alexander J McIntyre Nyree T Crawford Fiammetta Falcone Christopher McCann | 2020/7/28 |
